GlassScriptPhysician profile
William Logan Tontz
NPI 1659332682
$3,663.53
in general payments reported to CMS, 2019-2025
16 companies · $61.02 in 2025
The $61.02 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $900 · 2020: $451 · 2021: $307 · 2022: $1,880 · 2023: $45.58 · 2024: $18.34 · 2025: $61.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corelink, LLC | $1,885.33 | 2021-2022 | |
| Titan Spine, LLC | $459.43 | 2019 | |
| Medtronic USA, INC. | $411.79 | 2019-2020 | |
| Depuy Synthes Sales INC. | $224.34 | 2019-2020 | |
| Boston Scientific Corporation | $170.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $122.51 | 2020-2021 | |
| Kyocera Medical Technologies, INC. | $109.59 | 2020 | |
| Globus Medical, INC. | $61.02 | 2025 | Vyrsa V1 |
| Medtronic, INC. | $54.21 | 2022 | |
| Centinel Spine, LLC | $45.58 | 2023 | Prodisc C Vivo |
| Si-Bone, INC. | $41.15 | 2020 | |
| Saluda Medical Americas, INC. | $18.34 | 2024 | Evoke |
| Bioventus LLC | $15.63 | 2020 | |
| Arthrosurface Incorporated | $15.62 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.71 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $14.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Tontz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.